US Patent

US9155471 — Methods and systems for spatially identifying abnormal cells

Method of Use · Assigned to Lumicell Inc · Expires 2031-10-12 · 5y remaining

Vulnerability score 81/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects methods and systems for imaging tumor resections.

USPTO Abstract

The present invention provides compositions and methods for imaging tumor resections.

Drugs covered by this patent

pegulicianine-acetate (PEGULICIANINE ACETATE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3890`	—	pegulicianine-acetate

Patent Metadata

Patent number: US9155471
Jurisdiction: US
Classification: Method of Use
Expires: 2031-10-12
Drug substance claim: No
Drug product claim: No
Assignee: Lumicell Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.